Startups & Innovations: New Hires

By Jessie Yount, Orange County Business Journal

Modulim has named Charlie Huiner chief executive.

Huiner comes from the Irvine-based firm after nearly six years with Santa Barbara-based Sientra, Inc. (NASDAQ: SIEN), where he helped raise $375 million in equity financing including a successful IPO.

In his new role, Huiner will oversee Modulim’s Series C fundraising efforts and lead commercial strategy for its Clarifi imaging device, the company said.

“With Charlie’s experience and expertise, we are poised to build from a number of key milestones recently achieved by the Company to accelerate commercialization,” said Chief Technology Officer David Cuccia.

Modulim received CE Mark certification this month for its noninvasive, radiation-free imaging system, which produces images that resemble a thermal heat map.  Warmer colors signal better blood perfusion, while darker ones indicate low oxygenation.

The company’s product is largely focused on diagnosing and preventing the effects of diabetic foot ulcers.

Cuccia invented Modulim’s imaging technology at the UCI Beckman Laser Institute and introduced Clarifi to the U.S. market last fall.

The company has raised more than $21 million in public and private funds to date.

Read the full Orange County Business Journal article.

2021 SPIE-Franz Hillenkamp Postdoctoral Fellowship Awarded to Nitesh Katta

The annual award will support the development of Katta’s doctoral research, as well as his efforts to translate benchtop advancements into clinical successes

BELLINGHAM, Washington, USA — SPIE, the international society for optics and photonics, has announced Nitesh Katta, who received his PhD in 2019 from the University of Texas at Austin, as the winner of the 2021 SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics. The annual award of $75,000 supports interdisciplinary problem-driven research and provides opportunities for translating new technologies into clinical practice for improving human health.

Katta’s research project, “A cold laser wire (CLW) for true-lumen crossing of tortuous coronary arteries with calcified chronic total occlusions (CTOs)” — conducted in conjunction with Thomas Milner and Marc Feldman at the Beckman Laser Institute and Medical Clinic — will build on a challenge Katta discovered during his doctoral work: in recognizing an unmet need for piercing calcified material in performing true-lumen percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs), Katta, together with his then-doctoral mentors Milner and Feldman, invented intravascular cooling and guidance methodologies for achieving true-lumen crossing in CTOs using the cold laser wire. Katta’s aim is to bring this research into the clinical setting, addressing an urgent clinical need of a tool for safe PCI in patients suffering with CTOs.

“I am deeply grateful to receive this support from such a distinguished organization as SPIE and feel very humbled to have the SPIE-Hillenkamp fellowship committee recognize the value of this work,” says Katta. “Receiving this award will enable me to conduct the necessary research work and translational training to bring a medical device from a laboratory bench-top to the market where it can have a meaningful impact on percutaneous coronary intervention outcomes in patients suffering from chronic total occlusions.”

“This is a very exciting proposal from an excellent researcher working in a renowned lab for innovative research in biomedical optics and biophotonics that translates into solving medical problems,” said the Co-Chairs of the Hillenkamp Fellowship Committee Rox Anderson and Gabriela Apiou. “Nitesh’s work has the potential to establish a new class of simple and safe methods to operate endovascular light-based therapeutic devices, and we look forward to seeing the outcome of his work.”

Honoring the career of medical laser pioneer Franz Hillenkamp, the SPIE-Hillenkamp Fellowship is a partnership between multiple international biomedical laboratories — the Wellman Center for Photomedicine, the Beckman Laser Institute, the Manstein Lab in the Cutaneous Biology Research Center at Massachusetts General Hospital, Medical Laser Center Lübeck, and Boston University — and the Hillenkamp family. The endowment is funded through generous donations from the biomedical optics community, with SPIE contributing matching funds up to $1.5 million.

About SPIE

SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves more than 258,000 constituents from 184 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2020, SPIE provided over $5.8 million in community support including scholarships and awards, outreach and advocacy programs, travel grants, public policy, and educational resources. www.spie.org.

Read full SPIE press release.

Modulim Announces Seasoned Medical Device Executive Charles Huiner as Chief Executive Officer

Irvine, CA—Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, today announced that Charles Huiner has been named President and Chief Executive Officer (CEO). Huiner will start immediately and lead the Company’s Series C fundraising and execution of a focused growth strategy for its FDA-cleared product, Clarifi®.

Huiner brings over 25 years of executive experience with a successful leadership track record across multiple life science market segments including biotech, medical devices, and digital health. Most recently, he served as Chief Operating Officer and Senior Vice President, Corporate Development and Strategy for Sientra, Inc. (NASDAQ: SIEN), a global medical aesthetics company with annual revenues exceeding $80 million. While serving at Sientra, he authored the company’s growth strategy, led several key acquisitions, and helped execute $375 million in equity financing including a successful IPO. Prior to that, he was Vice President of Marketing and Business Development at InTouch Health during a transformative period that solidified the company’s market strategy and commercial model, leading to its eventual $600 million exit to Teladoc Health. Previously, as Senior Director of Corporate Development and Strategy at INAMED, Inc. he was instrumental in broadening the company’s product portfolio that contributed to its $3.3 billion acquisition by Allergan Aesthetics.

“It’s fantastic to have Charlie on-board to lead Modulim’s next phase,” said David Cuccia, Modulim’s Founder, Board member and Chief Technology Officer. “With Charlie’s experience and expertise, we are poised to build from a number of key milestones recently achieved by the Company to accelerate commercialization. The whole executive team looks forward to working with him to enact Modulim’s mission—to deliver transformative optical solutions that help people live healthier, longer lives.”

“I am excited for the opportunity to lead Modulim’s talented team. The Company will play a significant role in the ongoing convergence of medical diagnostic, predictive AI, and telehealth technologies to enable more efficient healthcare delivery. Our decision support solutions are applicable to numerous ill-met chronic conditions and vascular complications, starting with helping healthcare providers prevent costly and often deadly undiagnosed conditions brought on by diabetes and peripheral arterial disease,” said Huiner. “I look forward to working with my new colleagues to accelerate the adoption and expansion of our proprietary SFDI technology while improving the lives of patients.”

“We are pleased to have attracted a high caliber, proven executive like Charlie to strengthen the Company and advance on early successes with strategic customers,” said Janelle Goulard, Partner at Pangaea Ventures. “Charlie brings extensive technology commercialization knowledge and experience at this dynamic period of growth for Modulim. We believe the Clarifi solution will positively impact millions that are living with chronic conditions.”

About Modulim
Modulim is a privately held medical device company founded by the inventors of SFDI at the University of California Irvine with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Its mission is to deliver transformative optical solutions that help people live healthier, longer lives. Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised

Meet The World’s Newest – And Youngest – Self-Made Billionaire: Luminar’s Austin Russell

By Alan Ohnsman and Alexandra Sternlicht, Forbes

The race to commercialize self-driving car technology has attracted billions of dollars of investment but not created many billionaires. Luminar founder and CEO Austin Russell is among the rare exceptions. With today’s Nasdaq listing of the laser sensor company he founded at age 17, the optics prodigy is one of the first billionaires to emerge from the autonomous vehicle world–and the youngest self-made billionaire in the world.

“It’s been insanely intense, grueling … everything through every day that we’ve had to go through scaling this up. And of course it’s incredibly rewarding to have an opportunity to be able to get out there now and get into the public markets and scale through this IPO SPAC,” 25-year-old Russell tells Forbes in a video interview from his office in Palo Alto, California. “I’m still relatively young, but … a lot of blood, sweat and tears have gone into it. And I was fortunate enough to be able to retain a good enough stake.”

Good enough indeed. Russell’s 104.7 million shares, about a third of Luminar’s outstanding equity, is worth $2.4 billion at the start of Nasdaq trading today. The listing, announced in August, resulted from a merger with special purpose acquisition company Gores Metropoulos, a unit of Beverly Hills-based finance firm The Gores Group, and raised Luminar’s estimated market value to $3.4 billion. Investors in the newly public company include fellow billionaire Peter Thiel (net worth: $4.6 billion), who helped get Russell started with Luminar by making him a Thiel Fellow in 2012; Volvo Cars Tech Fund; Alec Gores of The Gores Group, another billionaire ($2.2 billion) who is also a Luminar board member; and billionaire Dean Metropoulos, the company’s chairman.

Thiel, the Paypal cofounder who famously created a fellowship offering extraordinary young people $100,000 to drop out of college to pursue their dreams, has been an advisor to Russell since he left Stanford to start Luminar in 2012. As a mentor, Thiel is impressed not just by the new tech billionaire’s intellect, but his ability to hold onto a significant chunk of Luminar as it moved from Russell’s garage concept to Nasdaq.

“You can build a billion-dollar business but that does not mean you can become a billionaire,” says Thiel. “It’s remarkable from a financing perspective to retain a financial stake of that size.”

Russell, who’s also a Forbes 30 Under 30 alum from the class of 2018, isn’t looking to take on self-driving tech giants like Alphabet’s Waymo or GM-backed Cruise, but instead is perfecting sensors that help autonomous cars “see” their surroundings by bouncing a laser beam off objects in their path. Known as Lidar for “light detection and ranging,” the technology is fundamental for autonomous vehicles and Luminar is competing in that space with Velodyne, the early leader in lidar for autonomous vehicles, and newcomer Aeva, both of which are also going public via SPAC mergers. Russell has sold prototype sensors to major auto companies for the past few years, but more recently secured production orders from Volvo Cars, Daimler and Intel’s Mobileye that may ensure revenue growth for several years.

Luminar will likely post sales of just $15 million this year, but could generate at least $1.3 billion by 2026, based on estimates in an SEC filing.

Russell’s abilities extend beyond the lab to the boardroom, according to Alec Gores, who helped arrange Luminar’s listing. “When we were negotiating, he was so on the top of everything, the small details. 60-year-old guys who’ve been in the business for 40 years don’t understand this stuff, but he took time to study the SPAC,” he says. “I’m looking at this guy and saying, ‘you asked more questions than anybody I’ve seen that’s been doing this sh*t for a long time.’”

The lanky 6’4” Russell, with shaggy strawberry blonde hair and a light beard to match, was making notable achievements long before his new billionaire status. As the story goes, he memorized the periodic table of elements at 2 years old and rewired his Nintendo DS game console into a crude mobile phone when he was in the sixth grade after his parents forbade him from having one. At 13, he filed his first patent: an underground water recycling system that catches sprinkler water and saves it for future gardening to reduce wastewater. Rather than go to high school, he spent his teen years at the University of California, Irvine’s Beckman Laser Institute.

Next came admission to Stanford to study physics, but that didn’t last long. He dropped out midway through his freshman year after winning a $100,000 Thiel Fellowship stipend for his lidar concept, founding Luminar not long after obtaining his driver’s license.

Excluding inherited fortunes, Russell is ​one of about a dozen people on the planet to make a billion dollars before they turned 30.

Lidar was an early fixation for Russell as he believes it has the potential to save lives both as part of self-diving cars and as a component of advanced driver-assistance systems that Volvo and other carmakers are bringing to market in the next two to three years. As a teenager, he’d looked at what Velodyne and other companies were doing with laser sensors, but determined a completely different approach was needed to make them cheap enough to be ubiquitous.

“It should not be a 16- or 17-year-old, and then subsequently a 25-year-old that can build a business like this,” says Russell. “We’ve been able to accelerate this because no one has really done this before.”

It doesn’t hurt that Russell has zero distraction from social media or time-sucking general education requirements of college and high school degrees. Unlike most 25-year-olds, he has neither Twitter nor Instagram accounts, but confesses to learning most of what he knows about the world from avid Wikipedia and YouTube explainer consumption.

As a Gen Y billionaire, Russell is also thinking about his impact. Though he has no immediate plans for Gates-like philanthropy, he sees his contribution as eradicating automobile accidents. “When this becomes a new, modern safety technology on vehicles that’s integrated on every vehicle globally produced, that’s when I’d firmly say that we’ve accomplished the goals that we set.”

Read full “Forbes” article.

ACES Summer Program Goes Viral

High-achieving, underrepresented students get a glimpse of graduate school

This past summer, the Institute hosted 10 students for the virtual Access to Careers in Engineering and Sciences (ACES) program. The UC Office of the President-supported Historically Black Colleges and Universities (HBCU) partner program funds this summer training initiative. The program introduces high-achieving, underrepresented undergraduate students to the possibilities of graduate education and the breadth of UCI graduate programs in the fields of biomedical engineering, biophotonics and related Science, Technology, Engineering and Math (STEM) disciplines.

ACES has resulted in the acceptance of five talented Black students to University of California campuses in STEM Ph.D. programs. Breyah Matthews joined the UCI Advanced Power and Electricity program in the Department of Electrical Engineering and is entering her third year of graduate study. Alexius Lampkin was accepted at UC Davis, but chose to attend University of Wisconsin as a Ph.D. student in Chemistry. In addition, Chris Johnson, Lauryn Alexander and Jakari Harris were accepted into Ph.D. programs at UCI. Chris is in his second year in the UCI Department of Biomedical Engineering. Lauryn matriculated at West Virginia University to pursue a Ph.D. in Forensic Sciences and Jakari Harris enrolled in a joint Ph.D. program in Biomedical Engineering at Georgia Tech/Emory University.

Ten UCI Beckman Laser Institute & Medical Clinic faculty among world’s top researchers

Study developed by Stanford University and published in PLOS Biology ranks top two percent of scientists

UCI Beckman Laser Institute & Medical Clinic Director Thomas Milner, Medical Director Stuart Nelson, Cofounder and Founding Director Michael Berns and seven Institute faculty are among the world’s top two percent of scientists. The list, which includes 445 UCI faculty, is based on standardized citation metrics developed by a team of scientists led by John P.A. Ioannidis, a statistician at Stanford University.

The study is published in the Public Library of Science Biology (PLOS Biology) journal.
The ten Institute faculty include:

Chris Barty, Ph.D., Distinguished Professor of Physics and Astronomy
Michael Berns, Ph.D., Distinguished Professor of Surgery and Biomedical Engineering
Zhongping Chen, Ph.D., Professor of Biomedical Engineering
Mark Fisher, M.D., Professor of Neurology
Enrico Gratton, Ph.D., Professor of Biomedical Engineering and Physics and Astronomy
Thomas Milner, Ph.D., Professor of Surgery and Biomedical Engineering
Stuart Nelson, M.D., Ph.D., Professor of Surgery and Biomedical Engineering
Eric Potma, Ph.D., Professor of Chemistry and Electrical Engineering and Computer Science
Vasan Venugopalan, Sc.D., Professor of Chemical and Biomolecular Engineering
Brian Wong, M.D., Professor of Surgery and Biomedical Engineering

Click here to read Public Library of Science Biology (PLOS Biology) journal: “Updated science-wide author databases of standardized citation indicators.”

New chairs appointed for the Departments of Neurology, Pediatrics and Dermatology

Kristen M. Kelly, MD, has been appointed chair for the University of California, Irvine School of Medicine Department of Dermatology, effective September 6, 2020.

Kelly is a board-certified dermatologist with more than 25 years of experience using lasers to treat vascular birthmarks, scars and other dermatologic conditions. She is at the forefront of research in the treatment of vascular skin conditions, and contributes to the development and implementation of the latest energy based technologies, techniques and treatments in dermatology.

“I have always been impressed and drawn to the spirit of collaboration and innovation embodied by the UCI School of Medicine and the Beckman Laser Institute,” said Kelly. “At UCI, I can provide the best care for my patients and participate in cutting edge research that can positively impact both individual patients and the field of dermatology.”

Kelly has contributed to the work at the world-renowned UCI Health Beckman Laser Institute & Medical Clinic in Irvine, California for over 20 years. She is also past president and board member of the American Society for Laser Medicine and Surgery and has lectured locally, nationally and internationally on the treatment of vascular lesions and light based treatments and diagnostics in dermatology.

Kelly replaces UCI physician Christopher B. Zachary, MD, MBBS, FRCP, who stepped down from the position after serving 15 years as chair of the Department of Dermatology.

“Dr. Zachary grew the department in wonderful ways and I want to continue this positive trajectory, broadening our clinical outreach with additional patient care sites and expanding our research faculty, collaborations and grant funding,” said Kelly. “We also intend to work with the Children’s Hospital of Orange County to augment pediatric dermatology services. “

Kelly has worked as a dermatologist and professor at UCI School of Medicine for more than 20 years. During her tenure as program director, she augmented and expanded the dermatology residency program achieving full accreditation and built the program to a highly desired residency where the department receives over 400 applications for five slots each year.

“We have an outstanding residency program and we want to continue to attract the top applicants in the country and expand our residency and fellowship programs,” said Kelly. “We want to embody the UCI School of Medicine vision statement and be ‘powered by discovery, innovation and inclusive excellence’.”

Kelly has also been involved in the American Society for Laser Medicine & Surgery, serving as a past president and now secretary elect. She has also worked with the Sturge-Weber Foundation and The Vascular Birthmarks Foundation to augment education about birthmarks, support the most innovative research in this field and expand access to the best treatment options to all patients.

“I have been fortunate to collaborate with outstanding scientists at UCI and across the globe looking at methods to advance energy based treatments, augment removal of vascular birthmarks and develop non-invasive diagnostic imaging systems for cutaneous disease,” said Kelly.

Kelly received her medical degree from UCLA, and completed an internship in internal medicine from St. Mary Medical Center in Long Beach. She completed her residency in dermatology at UCI.

The UCI Department of Dermatology has experts in medical and surgical dermatology with specialty clinics in skin cancer, blistering diseases, pigmentary disorders, gynecologic dermatology, vascular birthmarks, hair disorders, complex medical dermatology, laser surgery, Mohs surgery and cosmetic dermatology.

Click here to read the full UCI School of Medicine article.

Transforming Human Health at the COSI Labs

By Sandra Flores, UCI Beall Applied Innovation
Photos: Julie Kennedy, UCI Beall Applied Innovation

THE COSI LABS ARE HOME TO THE CREATION, CLINICAL TRANSLATION AND COMMERCIALIZATION OF LASER TECHNOLOGY THAT CAN BE USED TO FIGHT DISEASE AND ILLNESS.

Diseases are constantly evolving in our modern world, and with their evolution comes the need for new technology to combat them and sustain quality human health.

The Convergence Optical Sciences Initiative (COSI) labs, located in the Cove @ UCI, specializes in the creation, clinical translation and commercialization of trailblazing optics and photonic technologies to transform human health. The labs are prioritizing the  creation of laser technology that could benefit the health of those fighting chronic illnesses.

“Here at the labs, the main focus is the intersection of multiple areas such as physical science, biology, engineering, industry and medicine, all
around photonics,” said Chris Barty, distinguished professor of physics and astronomy at the UCI School of Physical Sciences and senior faculty
member of the COSI labs.

One of the main activities Barty is currently spearheading is the Laser Compton X-ray, an X-ray machine that works similarly to a laser pointer and is highly tunable. The application of this extremely precise X-ray has the potential to revolutionize disease detection and treatment.

“If we do what we say we’re going to do correctly, you’ll never remove a breast, you’ll never remove a prostate again,” said Barty. “It’ll transform human health.”

Students pursuing UCI’s dual Ph.D./M.D. program study how to enable better medical applications, while Physics graduate students come up with new ways that could make the X-ray source even better. Since the pandemic, Barty and the COSI labs’ small team of graduate students are also working on a compact UVC laser that would be able to denature the virus on surfaces.

As the COSI labs move forward, Barty hopes to change the way medical professionals use X-rays and lasers, making UCI Beall Applied Innovation a hub for X-ray and laser technology for the Orange County ecosystem.

“I would be thrilled if we had an X-ray source sitting at Beall Applied Innovation that acts as a national center for advanced radiography and radiology,” said Barty. “Being a part of Applied Innovation makes it really easy to pursue this vision at UCI.”

Learn more about the COSI labs at bli.uci.edu/convergence-optical-science-initiative.

Read full article in UCI Beall Applied Innovation’s “Rising Tide” Magazine.

Samueli School Welcomes 12 New Faculty Members

By Anna Lynn Spitzer, UCI Samueli School of Engineering

Twelve new faculty – ranging from assistant professors to experienced professionals, including three who have been appointed research center directors – are joining the Samueli School of Engineering for the 2020-21 academic year. This brings the total number of full-time faculty to 162.

BIOMEDICAL ENGINEERING

Thomas Milner
Professor, Biomedical Engineering and Surgery
Director, Beckman Laser Institute & Medical Clinic

Milner, an early investigator in photomedicine, has made important contributions in both surgery and diagnostics, including development of novel optical tomographic imaging modalities and laser surgical procedures for diagnosis and treatment of disease. An inventor on 55 U.S. patents, as well as five international patents licensed to six companies, he has authored 190 peer-reviewed articles and eight book chapters. Milner, who came to UCI from University of Texas, Austin, where he was the Joe King Professor at the Cockrell School of Engineering, is the recipient of the Coherent Young Investigator Award in Biomedical Optics, the Inventor of the Year award at the UT Austin and numerous grants from the National Institutes of Health. He is a fellow of the American Society for Laser Medicine & Surgery, the American Institute for Medical and Biological Engineering and the National Academy of Inventors.

Link: Beckman Laser Institute & Medical Clinic

Liangzhong (Shawn) Xiang
Associate Professor, Biomedical Engineering, and Radiological Sciences, School of Medicine

Research Interests: X-ray-induced acoustic computed tomography for in vivo radiation dosimetry and radiology, fast proton-induced acoustic imaging for precision proton therapy, and electroacoustic tomography-guided electroporation

Education: Ph.D., electrical engineering, South China Normal University

Xiang, who is affiliated with both the Beckman Laser Institute & Medical Clinic and the Chao Family Comprehensive Cancer Center, was the Lloyd G. and Joyce Austin Presidential (Assistant) Professor in the Department of Electrical and Computer Engineering and the Stephenson Cancer Center at the University of Oklahoma. He is a recipient of the student-nominated Nancy L. Mergler Faculty Mentor Award for Undergraduate Research, a research scholar award from the American Cancer Society, a postdoctoral fellowship award in prostate cancer research from the U.S. Department of Defense and the Sylvia Sorkin Greenfield Award for best paper published in medical physics from the American Association of Physicists in Medicine. A former postdoctoral fellow at Stanford, he is a member of the Acoustical Society of America, the Radiological Society of North America, the American Association of Physicists in Medicine and the International Society for Optical Engineering.

Link: TRUE Lab

Read full article on the UCI Samueli School of Engineering website.

Cognitive decline distorts political choices, UCI-led study says

Disconnect found between political affiliation, political decisions in the cognitively impaired

Identification along the liberal/conservative spectrum may last a lifetime, but cognitive decline distorts our political choices, according to the first-of-its-kind study led by the University of California, Irvine. For those who are cognitively impaired, identifying as being liberal or conservative loses its relationship to their political decision-making.

“We found that for the cognitively impaired, there was a significant loss of consistency between an individual’s political orientation and their political choices,” said Dr. Mark Fisher, neurology and political science professor and study corresponding author. “This interface of neurology and political science is highly relevant, given the questions surrounding voting by individuals with dementia.”

For the study – forthcoming in the Journal of the American Geriatrics Society – researchers evaluated the relationship between political ideology, political policy preferences and cognitive status. Study participants were 190 members of The 90+ Study, a UCI-led longitudinal investigation of the oldest-old, who are those aged 90 and older.

Participants completed a questionnaire indicating their political ideology and a variety of policy issues, ranging from federal spending on public schools and the environment to immigration rates and the death penalty. Six months later, they completed the same survey.

“Our analysis produced novel findings with important political implications,” said Davin Phoenix, associate professor of political science and study co-author. “Across the six-month survey interval, where individuals placed themselves ideologically remained quite consistent, whether or not they were cognitively impaired. However, among those with cognitive impairments, being liberal or conservative appears to function more as a self-identity label and less an orienting framework for judging policy. So the capacity of that ideological identification to help people make choices that are aligned with their true policy preferences comes into serious question.”

More than 90 percent of the survey participants voted in the 2016 election. This high level of civic engagement emphasizes the importance of understanding how cognitive decline affects the political behavior of older persons.

“Our findings suggest that older individuals experiencing cognitive decline have relatively stable ideological preferences, but these preferences lose their connection to political policy details. Future studies conducted during an election year may shed additional light on how this group of Americans is casting their ballot,” said Fisher.

The research team included Shawn Rosenberg, UCI professor of political science; Dana Greenia, UCI MIND research unit clinical research administrator; Maria M. Corrada-Bravo, UCI neurology professor; Dr. Claudia Kawas, UCI neurology professor; Annlia Paganini-Hill, UCI neurology project scientist; and Sierra Powell, political science professor, Mount San Antonio College. The study was supported by the National Institute on Aging, grant R01AG021055, and the UCI Medical Humanities Initiative.

Read full UCI News Press Release.